Mateusz Kaczmarek

Mateusz Kaczmarek

Mateusz Kaczmarek is a financial and technology journalist at TS2.tech, covering stocks, artificial intelligence, semiconductors and global market developments. A graduate of the Poznań University of Economics and Business, he previously worked in financial analysis before moving into business journalism. His reporting focuses on technology companies, market trends and the forces shaping global investment markets. Follow Mateusz Kaczmarek on Google News.

Data Center Boom Ignites PPL Corp (PPL) Stock Surge – Analysts Weigh In

Data Center Boom Ignites PPL Corp (PPL) Stock Surge – Analysts Weigh In

PPL shares have risen steadily in 2025. After trading near $31 in early 2024, PPL climbed above $37 by Oct 2025 marketbeat.com. Key metrics include a P/E of ~27–28, a PEG ratio ~2.6, and a beta ~0.66 marketbeat.com. Its 50-day moving average sits just below price, and the 200-day confirms an uptrend marketbeat.com. The 52-week range is $31.22–$37.81 marketbeat.com.
Is 3M Stock Poised for a Comeback? Key Facts & Analysts’ Take (Oct 2025)

Is 3M Stock Poised for a Comeback? Key Facts & Analysts’ Take (Oct 2025)

MMM shares trade around $149 as of Oct 10, 2025 ts2.tech. After rallying earlier in the year, the stock has pulled back in October. On Oct 10 it closed at $148.75 ts2.tech, down 2.7% on the day and about 6.4% below the prior week ts2.tech. The 52-week range is roughly $122–$164 ts2.tech, with year-to-date gains of about +10%. Volume has been moderate and volatility is near market average. Overall the stock has been range-bound in the high-$140s lately.
12 October 2025
Crypto CARNAGE: $20B Vanishes as Bitcoin Plummets – Will It Rebound?

Crypto CARNAGE: $20B Vanishes as Bitcoin Plummets – Will It Rebound?

The crypto meltdown unfolded late on Oct. 10, 2025. In a posting on Truth Social, President Trump threatened a “massive increase” in tariffs on Chinese goods and new controls on technology exports ts2.tech ts2.tech. The announcement reignited trade-war fears, spooking all risk assets. U.S. stock markets fell ts2.tech, but crypto was hit even worse. Traders exploiting high leverage were caught off guard: Bitcoin collapsed from ~$122K to below $119K within minutes, as panic-selling cascaded through auto-liquidations ts2.tech ts2.tech.
12 October 2025
Mexican Dining Crisis: Beloved Chains File Bankruptcy and Close Doors as Industry Hits Breaking Point

Mexican Dining Crisis: Beloved Chains File Bankruptcy and Close Doors as Industry Hits Breaking Point

In summary, a squeeze on mid-tier Mexican chains is underway: beloved sit-down restaurants are shuttering locations or reorganizing under bankruptcy, even as fast-casual Mexican concepts remain popular. Oversupply of similar full-service concepts, plus inflation and labor costs, have forced chains like Abuelo’s to downsize dramatically ibtimes.co.uk calcoasttimes.com. Experts say the fallout is a wake-up call – legacy diners must adapt or consolidate. On the bright side, overall demand for dining out is not collapsing, and consumer surveys show that most people still enjoy eating at restaurants restaurant.org. If economic headwinds ease by 2026 and companies innovate on value and experience, analysts forecast a gradual stabilization. For now, companies like Sysco and Chipotle trade near multi-year highs on bets of steady demand ts2.tech tickernerd.com, but the fate of smaller chains will hinge on their ability to cut costs and attract budget-conscious diners.
Budget Airline Bonanza: Frontier & Allegiant Expand Routes as Travel Demand Skyrockets

Budget Airline Bonanza: Frontier & Allegiant Expand Routes as Travel Demand Skyrockets

Despite economic worries, travel bookings are robust. U.S. travel forecasts show domestic leisure spending rising about 1.9% in 2025 ustravel.org. According to the U.S. Travel Association, Americans have “continued to prioritize travel” even with inflation concerns ustravel.org. Major carriers report booming bookings, especially for premium seats and long-haul routes. For example, Delta and United see surging business and first-class travel ts2.tech reuters.com. As Delta’s management noted, a six-week spike in corporate travel has finally returned ts2.tech.
Airline Stocks Face Turbulence: JetBlue Crashes 41% and Experts Sound Alarm

Airline Stocks Face Turbulence: JetBlue Crashes 41% and Experts Sound Alarm

JetBlue’s stock has been battered recently. Despite raising its Q3 guidance in September, investors remain skeptical. The airline’s Jul–Sep earnings showed a loss of $0.16 per share marketbeat.com. JetBlue’s heavy debt load and sub‐1x price/sales make it vulnerable as yields soften. Credit and equity analysts are cautious: Weiss Ratings’ Oct 9 report gave JBLU a “sell” rating marketbeat.com. MarketBeat notes that 7 analysts now rate JBLU Hold and 5 rate Sell, yielding a consensus price target of just $5.28 marketbeat.com.
Trump Axes 6.2GW “Vegas-Sized” Solar Farm in Nevada – Renewable Energy Industry Reels

Trump Axes 6.2GW “Vegas-Sized” Solar Farm in Nevada – Renewable Energy Industry Reels

BLM on Oct 10 listed the Esmeralda 7 solar project in Nevada as “cancelled” energyconnects.com theguardian.com. The massive project would have generated ~6,200 MW – enough for nearly 2 million homes pv-magazine-usa.com theguardian.com. Interior Secretary Doug Burgum’s Trump administration said developers can now submit individual proposals instead of one programmatic EIS energyconnects.com electrek.co. Conservationists and some locals celebrated the cancellation, while clean‑energy advocates warned it’s a blatant rollback of renewables: NRDC’s Kabir Green calls it “unfettered obstruction” of clean-energy projects pv-magazine-usa.com. The cancellation comes amid a broader Trump‐era push against renewables: Congress has cut federal tax credits and DOI now requires Burgum to personally sign off on wind/solar projects energyconnects.com reuters.com. As a result, U.S. solar stocks have faltered – NextEra sits around ~$80–83 per share in early Oct ts2.tech investing.com – and analysts warn of a “boom‐bust” cycle if subsidies vanish ts2.tech ts2.tech. Still, global investment in renewables remains at record highs ts2.tech, and experts like Gina McCarthy note companies “remain committed to clean energy investments despite the policy headwinds” ts2.tech.
Circle (CRCL) Stock’s Wild Ride: Stablecoin Boom, Volatile Swings & 2025 Outlook

Circle (CRCL) Stock’s Wild Ride: Stablecoin Boom, Volatile Swings & 2025 Outlook

October 2025 has been eventful for Circle, with major partnership news and stock volatility grabbing headlines. On Sept 30, Circle revealed a collaboration with Deutsche Börse, one of the world’s largest market infrastructure providers, to integrate its stablecoins into traditional capital markets ts2.tech. This deal will explore listing USDC/EURC on Deutsche Börse’s trading platforms and using Circle’s coins in settlement and custody via the exchange’s networks ts2.tech. Around the same time, Circle announced fintech firms Arf and Huma joined its Circle Payments Network to offer credit and liquidity services in USDC ts2.tech – part of Circle’s push to increase stablecoin utility in global payments.
Uranium Energy Corp (UEC) Stock Skyrockets on Nuclear Boom – Key Facts & Outlook

Uranium Energy Corp (UEC) Stock Skyrockets on Nuclear Boom – Key Facts & Outlook

Uranium Energy Corp is a U.S.-based uranium mining and exploration company founded in 2003. Headquartered in Corpus Christi, Texas, UEC has become “America’s largest and fastest growing supplier of uranium” for nuclear energy prnewswire.com. The company’s business model focuses on low-cost in-situ recovery mining in the United States and high-grade conventional uranium projects in Canada prnewswire.com. This two-pronged approach lets UEC rapidly develop domestic uranium sources while also holding stakes in some of the world’s richest uranium districts.
11 October 2025
NewAmsterdam Pharma (NAMS) Stock Soars on Cholesterol Drug Breakthrough – What Investors Should Know

NewAmsterdam Pharma (NAMS) Stock Soars on Cholesterol Drug Breakthrough – What Investors Should Know

NewAmsterdam Pharma Company N.V. is a Netherlands-based biotech on a mission to “change the landscape of lipid-lowering treatment” for cardiovascular disease Newamsterdampharma. Founded in early 2020, the company sprang from the vision of Prof. John J.P. Kastelein – a world-renowned expert in lipid disorders – and venture capital firm Forbion Newamsterdampharma. They acquired the rights to obicetrapib, a once-abandoned CETP inhibitor, from an Amgen subsidiary in 2020 Newamsterdampharma. Soon after, Dr. Michael Davidson joined as co-founder and CEO, bringing deep clinical expertise to the leadership team Newamsterdampharma.
11 October 2025
Broadcom’s AI Windfall: Inside AVGO’s Trillion-Dollar Surge, $10B Chip Deal & 2025 Outlook

Broadcom’s AI Windfall: Inside AVGO’s Trillion-Dollar Surge, $10B Chip Deal & 2025 Outlook

Broadcom’s stock has been on a meteoric rise in 2023–2025, riding the twin waves of AI chip euphoria and strategic acquisitions. Even after the recent market volatility, AVGO is up dramatically year-to-date and over the past 12 months. At the start of 2024, Broadcom’s market cap was around $300 B; by October 2025 it ballooned past $1.5 trillion ts2.tech. The company’s decision to enact a 10:1 stock split helped spur retail interest, while its fundamental performance justified the climb.
TSMC’s AI-Fueled Surge: Record Highs, Big Risks, and Bold Predictions (Oct 2025 Update)

TSMC’s AI-Fueled Surge: Record Highs, Big Risks, and Bold Predictions (Oct 2025 Update)

TSMC is riding a wave of investor enthusiasm as of October 2025. Its Taipei-listed shares hit record highs this month – reaching NT$1,370 on Oct 2 ts2.tech – and the U.S. ADR likewise surged to all-time highs, briefly trading above $300. In fact, TSMC’s U.S. stock spiked to an intraday $307 on Oct 7 amid frenzied buying ts2.tech. Even after a bit of profit-taking, TSMC hovers around the mid-$290s per share as of Oct 11, reflecting a dramatic upswing from roughly ~$200 at the start of the year ts2.tech. Year-to-date, the stock has climbed on the order of 30–45% – vastly outperforming the broader market and semiconductor index. For context, TSMC’s Taipei shares are up 34% in 2025 vs ~18.5% for the Taiwan market reuters.com. This rally has elevated TSMC’s market capitalization to around US$1.1 trillion ts2.tech, cementing its status as one of the world’s most valuable tech companies.
Trump Media’s Wild Ride: DJT Stock Soars on Politics, Crypto & Controversy

Trump Media’s Wild Ride: DJT Stock Soars on Politics, Crypto & Controversy

As of mid-October 2025, DJT stock hovers around $15–$16, a far cry from its highs. It closed at $15.97 on October 10, 2025 investing.com investing.com, continuing a downward trend. The stock has lost roughly half its value in 2025 alone, and over the past year it’s down about 32% tickernerd.com. For context, DJT’s 52-week range spans from $15.42 up to $54.68 investing.com tickernerd.com – meaning it has collapsed about 70% from its peak. That peak came amid tremendous enthusiasm earlier in Trump’s presidential term, but momentum has since faded.
Robinhood’s Wild 2025 Ride: HOOD Stock Skyrockets 200%, Plunges 9% in a Day – What’s Next?

Robinhood’s Wild 2025 Ride: HOOD Stock Skyrockets 200%, Plunges 9% in a Day – What’s Next?

Robinhood’s stock has been on a rollercoaster in 2025. After starting the year at much lower levels, HOOD nearly tripled in value by early October. On October 6, shares hit a record intra-week high around $153. But by the week’s end, the stock pulled back sharply, closing at $138.96 on Oct 10 after an 8.9% single-day plunge ts2.tech. Even after the pullback, Robinhood remains up over 200% year-to-date, vastly outperforming the S&P 500’s return for 2025 ts2.tech. Its 52-week trading range tells the tale of this explosive growth – HOOD traded as low as roughly $22 per share over the past year and as high as $153 ts2.tech.
Quoin Pharma (QNRX) Stock Skyrockets 150% on Funding Deal – What’s Next?

Quoin Pharma (QNRX) Stock Skyrockets 150% on Funding Deal – What’s Next?

Quoin Pharmaceuticals Ltd. is a clinical-stage biotech specializing in rare dermatological diseases. Headquartered in Ashburn, VA, Quoin’s mission is to deliver the first approved therapies for conditions that currently have none. “We remain fully focused on delivering the first approved therapy for Netherton Syndrome,” said CEO Dr. Michael Myers globenewswire.com. The company’s pipeline comprises three main product candidates targeting multiple orphan indications finviz.com:
11 October 2025
Protagonist Therapeutics: Small Biotech Skyrockets on Buyout Buzz & Breakthrough Trials

Protagonist Therapeutics: Small Biotech Skyrockets on Buyout Buzz & Breakthrough Trials

Protagonist Therapeutics is a clinical-stage biopharma company leveraging peptide technology to create new medicines for rare hematologic conditions and prevalent immunological diseasesprotagonist-inc.com. Founded in 2008, Protagonist has built its identity around engineered peptide drugs – a niche between small molecules and antibodies – to tackle challenging targets with oral or injectable therapies. The company’s mission centers on “developing groundbreaking new medicines to treat both rare and prevalent diseases” using its proprietary peptide platformprotagonist-inc.com. This focus has led to a pipeline addressing blood cancers/disorders and inflammatory bowel and skin diseases, where current treatments are inadequate.
Amazon Stock Today: AI Ambitions, $2.5B Twist, and $3 Trillion Dreams

Amazon Stock Today: AI Ambitions, $2.5B Twist, and $3 Trillion Dreams

Amazon’s stock has experienced back-and-forth swings in recent weeks. As of the market close on Oct. 10, 2025, AMZN stood at $216.37 per share stockanalysis.com. This price reflects a sudden drop at the end of the week – on Oct. 10 the stock plunged nearly 5% in a single day stockanalysis.com, part of a broader sell-off after U.S. President Trump threatened new 100% tariffs on Chinese imports and China tightened exports of rare earths investopedia.com reuters.com. Prior to that downturn, Amazon had been gradually rebounding from a late-September dip: shares had bounced from around $219 in early October up to the mid-$220s by mid-week ts2.tech. In fact, Oct. 9 marked Amazon’s fourth straight up-day, closing near $228, before the tariff news erased those gains.
Tesla Stock’s October Shock: Record Sales, New “Affordable” Models & Wall Street’s Verdict

Tesla Stock’s October Shock: Record Sales, New “Affordable” Models & Wall Street’s Verdict

Tesla’s stock has seen dramatic swings in early October 2025. After trading in the low-$400s to start the month, TSLA spiked on October 6 ahead of a big product announcement, jumping ~5.4% in one session to close at $453.25 ts2.tech. That surge – adding over $70 billion in market cap – was fueled by optimism around record Q3 sales and a teased new model. It capped a strong short-term run: Tesla shares climbed roughly 7–8% over the first two weeks of October, outperforming the broader market ts2.tech ts2.tech. Notably, 7 of 10 trading days were positive during that stretch ts2.tech. At mid-$450s, Tesla was trading near its 52-week high and more than 50% above its yearly low ts2.tech. In fact, over the past 12 months TSLA was up about 81%, a huge run compared to ~17% for the S&P 500 in the same period ts2.tech.
Rare Earth Goldmine? MP Materials Stock Skyrockets on Pentagon Deal & China Tensions

Rare Earth Goldmine? MP Materials Stock Skyrockets on Pentagon Deal & China Tensions

MP Materials’ stock performance in 2025 has been nothing short of remarkable. Shares have exploded higher on the back of transformative deals and the prospect of a secure American rare-earth supply chain. The stock is up nearly 4-fold this year, recently trading around $75–$80 per share ts2.tech. In late August, MP hit an all-time high near $82 before a brief pullback ts2.tech. Even after cooling slightly, shares remain ~350% above where they started the year. Elevated trading volume accompanied this rally, signaling intense investor interest.
1 117 118 119 120 121 173
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

AerCap

NYSE: AER 95 / 100
#2 BUY

Uber

NYSE: UBER 93 / 100
#3 BUY ON WEAKNESS

Taiwan Semiconductor

NYSE: TSM 91 / 100
#4 TACTICAL BUY

dLocal

NASDAQ: DLO 88 / 100
#5 BUY THE RESET

Tapestry

NYSE: TPR 86 / 100
View full portfolio
Editorial model selection. Not personalised advice.